Prevalence and clinical characteristics of white-coat hypertension based on different definition criteria in untreated and treated patients

Journal of Hypertension

Volumn 35, Issue 12, 2017, Pages 2388-2394

  De La Sierra, Alejandro ^a   Vinyoles, Ernest ^b   Banegas, José R ^c   Segura, Julián ^d   Gorostidi, Manuel ^e   De La Cruz, Juan J ^c   Ruilope, Luis M ^c,d,f  

^a UNIVERSITY OF BARCELONA   (Spain)

^b La Mina Primary Health Care Centre   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^f UNIVERSIDAD EUROPEA DE MADRID   (Spain)

Author keywords

ambulatory blood pressure monitoring; cardiovascular risk; circadian pattern; white coat hypertension

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NIGHT; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; WHITE COAT HYPERTENSION; BLOOD PRESSURE; CROSS-SECTIONAL STUDY; PHYSIOLOGY; RISK FACTOR;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CROSS-SECTIONAL STUDIES; HUMANS; PREVALENCE; RISK FACTORS; WHITE COAT HYPERTENSION;

EID: 85025175370     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000001493     Document Type: Article

References (23)

1. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34:2159-2219.
2. Piper MA, Evans CV, Burda BU, Margolis KL, O'Connor E, Whitlock EP. Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2015; 162:192-204.
3. Pickering TG, James GD, Boddie G, Harshfield GA, Blank S, Laragh JH. How common is white-coat hypertension? JAMA 1988; 259:225-228.
4. O'Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al., European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 2013; 31:1731-1768.
5. De la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P, et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 2011; 57:898-902.
6. Vinyoles E, Felip A, Pujol E, de la Sierra A, Durà R, del Rey RH, et al., Spanish Society of Hypertension ABPM Registry. Clinical characteristics of isolated clinic hypertension. J Hypertens 2008; 26:438-445.
7. Gorostidi M, Vinyoles E, Banegas JR, de la Sierra A. Prevalence of white-coat and masked hypertension in national and international registries. Hypertens Res 2015; 38:1-7.
8. Franklin SS, Thijs L, Hansen TW, Li Y, Boggia J, Kikuya M, et al., International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators. Significance of white coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in relation to Cardiovascular Outcomes Population. Hypertension 2012; 59:564-571.
9. Franklin SS, Thijs L, Asayama K, Li Y, Hansen TW, Boggia J, et al., IDACO Investigators. The cardiovascular risk of white-coat hypertension. J Am Coll Cardiol 2016; 68:2033-2043.
10. Cuspidi C, Rescaldani M, Tadic M, Sala C, Grassi G, Mancia G. Whitecoat hypertension, as defined by ambulatory blood pressure monitoring, and subclinical cardiac organ damage: a meta-analysis. J Hypertens 2015; 33:24-32.
11. Verdecchia P, Reboldi GP, Angeli F, Schillaci G, Schwartz JE, Pickering TG, et al. Short-and long-term incidence of stroke in white-coat hypertension. Hypertension 2005; 45:203-208.
12. Briasoulis A, Androulakis E, Palla M, Papageorgiou N, Tousoulis D. White-coat hypertension and cardiovascular events: a meta-analysis. J Hypertens 2016; 34:593-599.
13. De la Sierra A, Vinyoles E, Banegas JR, Parati G, de la Cruz JJ, Gorostidi M, et al. Short-term and long-term reproducibility of hypertension phenotypes obtained by office and ambulatory blood pressure measurements. J Clin Hypertens (Greenwich) 2016; 18:927-933.
14. Asayama K, Thijs L, Li Y, Gu YM, Hara A, Liu YP, et al., International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes (IDACO) Investigators. Setting thresholds to varying blood pressure monitoring intervals differentially affects risk estimates associated with white-coat and masked hypertension in the population. Hypertension 2014; 64:935-942.
15. Banegas JR, Segura J, Sobrino J, Rodr?guez-Artalejo F, De la Sierra A, De la Cruz JJ, et al., Spanish Society of Hypertension Ambulatory Blood Pressure Monitoring Registry Investigators. Effectiveness of blood pressure control outside the medical setting. Hypertension 2007; 49:62-68.
16. De la Sierra A, Redon J, Banegas JR, Segura J, Parati G, Gorostidi M, et al. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension 2009; 53:466-472.
17. Banegas JR, Ruilope LM, de la Sierra A, de la Cruz JJ, Gorostidi M, Segura J, et al. High prevalence of masked uncontrolled hypertension (MUCH) in people with treated hypertension. Eur Heart J 2014; 35:3304-3312.
18. De la Sierra A, Gorostidi M, Marin R, Redon J, Banegas JR, Armario P, et al. Evaluation and management of hypertension in Spain. A consensus guide. Med Clin (Barc) 2008; 131:104-116; [Article in Spanish].
19. Franklin SS, Thijs L, Hansen TW, O'Brien E, Staessen JA. White-coat hypertension. New insights from recent studies. Hypertension 2013; 62:982-987.
20. Mancia G, Grassi G. The heterogeneous nature of white-coat hypertension. J Am Coll Cardiol 2016; 68:2044-2046.
21. Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta-analysis. Am J Hypertens 2011; 24:52-58.
22. Mancia G, Bombelli M, Brambilla G, Facchetti R, Sega R, Toso E, Grassi G. Long-term prognostic value of white coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements. Hypertension 2013; 62:168-174.
23. De la Sierra A. Definition of white-coat hypertension: ambulatory blood pressure, self-measured blood pressure, or both? Hypertension 2013; 62:16-17.